Frontlight ResearchEarly access
Trial site
City of Hope - Lennar
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Ovarian cancer2 trials
- Multiple myeloma1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 1/23 trials
- Phase 32 trials
- Phase 21 trial
- Status
- Recruiting4 trials
- Active, not recruiting1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company2 trials
- Disc Medicine, Inc1 trial
- Fortvita Biologics (USA)Inc.1 trial
- Revolution Medicines, Inc.1 trial
- University of Colorado, Denver1 trial
Running trials
Recruiting
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Recruiting
Recruiting
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Recruiting
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ovarian cancer2 recruiting
- Lung cancer1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026